Search - Prime Therapeutics
Navigate to
-
Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Tap into our Expert Clinical Network Gain insights from leading key opinion leaders (KOLs) to drive better care. Breadcrumb Home Our solutions Specialty drug management Medical pharmacy Expert...
-
See our CSR efforts As outlined in our 2023 Corporate Social Responsibility Report, we're committed to creating sustainable social change, rallying around our common purpose. Read the report...
-
Leading GLP-1 persistence, adherence and clinical outcomes research helps inform health plans and members
PA Sub-Categories: GLP-1 Prime Article: Perspectives -
Build healthier communities By delivering affordable, reliable services that help improve health outcomes and coordinate care, we help you get your members the resources they need to live healthier...
-
Event features discussions about health care industry trends, best practices and innovations
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Findings also show improved persistence with high-potency, obesity-approved GLP-1 products
PA Sub-Categories: GLP-1 Prime Article: Press Releases -
Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024
Prime Article: Stories -
Prime Therapeutics researchers share how the model helps to optimize drug therapy and lower costs
PA Sub-Categories: Technology Prime Article: Perspectives -
Hero headline Forward copy that anchors in the key themes of our campaign: we are an organization you can trust, with solutions built for every plan, and people who will work to do what is right...
-
Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Press Releases -
-
Diversity, equity and inclusion Our commitment to diversity, equity and inclusion (DEI) is rooted in our purpose and dedication to serving others. Breadcrumb Home Who we are Culture Diversity,...
-
Prime Careers Spotlight: November 2024 Check out our latest job openings. Together, we can help make health care better by helping clients and members navigate pharmacy benefits. Investment...
-
A look at the specialty landscape and how Prime delivers value to employers
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...
PA Sub-Categories: Specialty drugs Products Prime Article: Stories -
publications Pancreatic cancer: Innovative therapy approved, but unmet need continues April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth...
-
Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...
PA Sub-Categories: GLP-1 Technology Specialty drugs Products Prime Article: Perspectives -
Breadcrumb Home Newsroom Custom Content Prime Careers Spotlight Prime Careers Spotlight: October 2025 Prime Careers Spotlight: October 2025 Check out our latest job openings. Together, we can help...